Globus Medical (GMED) Shares Outstanding (2011 - 2026)

Globus Medical (GMED) has 16 years of Shares Outstanding (Entity) data on file, last reported at $113.2 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) changed 0.27% year-over-year to $113.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $113.2 million (changed 0.27% YoY) and the FY2025 annual result came in at $112.6 million, down 2.06% from the prior year.
• Shares Outstanding (Entity) improved to $113.2 million in Q1 2026, from $112.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $118.2 million in Q3 2023 to a low of $99.7 million in Q3 2022.
• A 5-year average of $109.0 million and a median of $112.6 million in 2025 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) advanced 18.58% — and 2024, when it declined 3.97%.
• Tracing GMED's Shares Outstanding (Entity) over 5 years: stood at $100.5 million in 2022, then grew by 13.37% to $113.9 million in 2023, then rose by 0.95% to $115.0 million in 2024, then declined by 2.06% to $112.6 million in 2025, then rose by 0.54% to $113.2 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $113.2 million (Q1 2026), $112.6 million (Q4 2025), and $112.2 million (Q3 2025), per Business Quant data.